For billions of years, bacteria have waged an ongoing arms race against viruses, evolving many defense mechanisms against the infectious invaders. Now, these evolutions may offer innovative ways for ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

This image shows patient derived tumor organoids before (top) and after treatment (bottom). The colors show the activation of pathways related to cell differentiation in cancer stem cells. Shortly ...

Investing.com -- Galapagos stock fell 15% after the biotechnology company announced it would wind down its cell therapy business following unsuccessful attempts to find a buyer for the unit. The ...

Galapagos NV is winding down its cell and gene therapy (CGT) division after an unsuccessful attempt to sell the unit, becoming the latest biotech to retreat from a sector that has lost momentum after ...

Galapagos (NASDAQ:GLPG) ADRs dropped ~13% in the premarket on Tuesday after the Belgian biotech announced plans to wind down its cell therapy business, impacting roughly 365 employees in Europe, the U ...

Zaw Thiha Tun is currently an investment advisor for PI Financial Corp. He is also a financial writer on a wide variety of topics. Vikki Velasquez is a researcher and writer who has managed, ...